The development of robust clinical trial methodologies increasingly relies on advanced statistical frameworks for model selection and the characterisation of dose–response relationships. With modern ...

In the intricate dance of balancing efficiency and performance within AI projects, the selection among sparse, small and large models isn't just a technical decision—it's a strategic imperative that ...